Daily non-political popular news in brief.

Assessment model based on medical history gauges lung cancer risk

Clinicians may be one step closer to having a critical tool in identifying which smokers are at higher risk for developing lung cancer, the deadliest of all cancers, thanks to an assessment model generated by researchers at the University of Texas M. D. Anderson Cancer Center.

Read more »

Keywords: assessment, model, based, medical, history, gauges, lung, cancer, risk, gauge

« Previous | Next »

Similar news on "Assessment model based on medical history gauges lung cancer risk":

1. Study reveals improved prediction of prostrate cancer
   01-30-2008 · EurekAlert!
   Scientists are another step closer to understanding why some people suffer from life-threatening diseases such as cancer. Research published in the new online open access journal BMC Medical Genomics reveals a model that may enable more accurate prediction of the risk of prostate cancer progression. By combining the Gleason score (a pathological score given to prostate cancer based on its microscopic appearance) with structured data from biomarker assessments, the researchers have developed a model for predicting the likelihood of prostate cancer virulence.
   Similar news · Read more »
   
2. New lung cancer guidelines oppose general CT screening
   09-10-2007 · EurekAlert!
   New evidenced-based guidelines from the American College of Chest Physicians provides 260 of the most comprehensive recommendations related to lung cancer prevention, screening, diagnosis, staging and medical and surgical treatments.
   Similar news · Read more »
   
3. Impaired Gene Helps Nonsmall-cell Lung Cancer Resist Drug
   10-02-2006 · ScienceDaily
   Lung cancer cells with a defective version of a potential tumor suppressor gene are highly resistant to attack by a platinum-based drug commonly used to treat the disease, researchers at the University of Texas M. D. Anderson Cancer Center and the University of Texas Southwestern Medical Center at Dallas report in the cover article of the Oct. 1 edition of Cancer Research.
   Similar news · Read more »
   
4. Other highlights in the Nov. 13 JNCI
   11-13-2007 · EurekAlert!
   Other highlights in the Nov. 13 JNCI include a simple model to predict breast cancer risk, the link between smoking and rectal cancer, research into how a cancer drug causes heart damage, a gene that may inhibit lung cancer, BRCA1's influence on drug response, and the difficulties assigning patients to cancer subtypes.
   Similar news · Read more »
   
5. Novel EGFR antibody outperforms cetuximab in mouse model of lung cancer
   01-26-2007 · EurekAlert!
   A study conducted at the Dana-Farber Cancer Institute and the Ludwig Center at Dana-Farber/Harvard Medical School now suggests that antibodies binding a particular protein conformation, caused by hyperactivation, might have distinct therapeutic advantages over antibodies, like cetuximab, that bind to wild-type (normal) target proteins.
   Similar news · Read more »
   
6. Herceptin does not increase heart failure in patients long-term
   06-03-2007 · EurekAlert!
   Risk of congestive heart failure in women treated with trastuzumab and combination chemotherapy for early-stage breast cancer did not increase over time according to a five-year follow-up of National Surgical Adjuvant Breast and Bowel Project trial B-31 led by the University of Pittsburgh School of Medicine. Based on the findings, the research team developed a prediction model to help oncologists assess the risk of heart failure in individual breast cancer patients prior to treatment with Herceptin and chemotherapy.
   Similar news · Read more »
   
7. Johns Hopkins develops pancreas cancer risk model
   04-16-2007 · EurekAlert!
   People with a family history of pancreas cancer now have a way to accurately predict their chance of carrying a gene for hereditary pancreas cancer and their lifetime risk of developing the disease. Developed by Johns Hopkins Kimmel Cancer Center researchers, the novel computer software tool is designed to help genetic counselors and physicians decide who would most benefit from early screening.
   Similar news · Read more »
   
8. Online tool supports more dialogue on prostate cancer risk
   02-04-2008 · EurekAlert!
   A comprehensive, clinical nomogram tool, the Sunnybrook Prostate Cancer Risk Calculator -- the first to use all known risk factors for prostate cancer -- is available online to help men determine individual prostate cancer risk in consultation with their primary care physician. A nomogram is a statistical model to determine risk for disease based on risk factors using a table and chart format.
   Similar news · Read more »
   
9. Dual gene therapy suppresses lung cancer in preclinical test
   01-15-2007 · EurekAlert!
   Combination gene therapy delivered in lipid-based nanoparticles drastically reduces the number and size of human non-small cell lung cancer tumors in mice, researchers at The University of Texas M. D. Anderson Cancer Center and the University of Texas Southwestern Medical Center report in the January 15 edition of Cancer Research.
   Similar news · Read more »
   
10. Herceptin does not increase heart failure in patients long term
    06-03-2007 · EurekAlert!
    Risk of congestive heart failure in women treated with trastuzumab and combination chemotherapy for early stage breast cancer did not increase over time according to a five-year follow up of National Surgical Adjuvant Breast and Bowel Project trial B-31 led by the University of Pittsburgh School of Medicine. Based on the findings, the research team developed a prediction model to help oncologists assess the risk of heart failure in individual breast cancer patients prior to treatment with Herceptin and chemotherapy.
    Similar news · Read more »